These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33682731)

  • 1. Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.
    Mestre TA; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Marinus J; Mollenhauer B; Postuma R; Rajalingam R; Rodríguez-Violante M; Simuni T; Surmeier DJ; Weintraub D; McDermott MP; Lawton M; Marras C
    J Parkinsons Dis; 2021; 11(2):395-404. PubMed ID: 33682731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
    Marras C; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; Van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Mollenhauer B; Postuma RB; Rodríguez-Violante M; Simuni T; Weintraub D; Lawton M; Mestre TA
    Mov Disord; 2024 Mar; 39(3):462-471. PubMed ID: 38243775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of Parkinson's Disease Subtypes.
    Marras C; Chaudhuri KR; Titova N; Mestre TA
    Neurotherapeutics; 2020 Oct; 17(4):1366-1377. PubMed ID: 32749651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducibility of data-driven Parkinson's disease subtypes for clinical research.
    Mestre TA; Eberly S; Tanner C; Grimes D; Lang AE; Oakes D; Marras C
    Parkinsonism Relat Disord; 2018 Nov; 56():102-106. PubMed ID: 30056038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Parkinson's Disease Subtypes and Related Attributes.
    Shakya S; Prevett J; Hu X; Xiao R
    Front Neurol; 2022; 13():810038. PubMed ID: 35677337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?
    Fereshtehnejad SM; Postuma RB
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):34. PubMed ID: 28324303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmotor Parkinson's and Future Directions.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1493-1505. PubMed ID: 28805581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.
    Albrecht F; Poulakis K; Freidle M; Johansson H; Ekman U; Volpe G; Westman E; Pereira JB; Franzén E
    Parkinsonism Relat Disord; 2022 Sep; 102():19-29. PubMed ID: 35932584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.
    Lee SH; Park SM; Yeo SS; Kwon O; Lee MK; Yoo H; Ahn EK; Jang JY; Jang JH
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
    Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
    JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-driven subtyping of Parkinson's disease: comparison of current methodologies and application to the Bochum PNS cohort.
    Chen Q; Scherbaum R; Gold R; Pitarokoili K; Mosig A; Zella S; Tönges L
    J Neural Transm (Vienna); 2023 Jun; 130(6):763-776. PubMed ID: 37000269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes.
    Belvisi D; Fabbrini A; De Bartolo MI; Costanzo M; Manzo N; Fabbrini G; Defazio G; Conte A; Berardelli A
    Mov Disord; 2021 Feb; 36(2):370-379. PubMed ID: 33037859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtypes of Parkinson's disease: state of the field and future directions.
    Marras C
    Curr Opin Neurol; 2015 Aug; 28(4):382-6. PubMed ID: 26110797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort.
    Lawton M; Baig F; Toulson G; Morovat A; Evetts SG; Ben-Shlomo Y; Hu MT
    Mov Disord; 2020 Feb; 35(2):279-287. PubMed ID: 31693246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Medicine and Nonmotor Symptoms in Parkinson's Disease.
    Titova N; Chaudhuri KR
    Int Rev Neurobiol; 2017; 134():1257-1281. PubMed ID: 28805572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes.
    Boccalini C; Carli G; Pilotto A; Padovani A; Perani D
    Neurobiol Dis; 2022 Jun; 167():105668. PubMed ID: 35219854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function in different motor subtypes of Parkinson's disease: A systematic review protocol.
    Child B; Saywell I; da Silva R; Collins-Praino L; Baetu I
    Health Sci Rep; 2024 May; 7(5):e2092. PubMed ID: 38706802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor subtype changes in early Parkinson's disease.
    Eisinger RS; Hess CW; Martinez-Ramirez D; Almeida L; Foote KD; Okun MS; Gunduz A
    Parkinsonism Relat Disord; 2017 Oct; 43():67-72. PubMed ID: 28754232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain connectivity for subtypes of parkinson's disease using structural MRI.
    Samantaray T; Saini J; Pal PK; Gupta CN
    Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38224618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.